Literature DB >> 25427102

Acetylation of trehalose mycolates is required for efficient MmpL-mediated membrane transport in Corynebacterineae.

Yoshiki Yamaryo-Botte, Arek K Rainczuk, David J Lea-Smith, Rajini Brammananth, Phillip L van der Peet, Peter Meikle1, Julie E Ralton, Thusita W T Rupasinghe, Spencer J Williams, Ross L Coppel, Paul K Crellin, Malcolm J McConville.   

Abstract

Pathogenic species of Mycobacteria and Corynebacteria, including Mycobacterium tuberculosis and Corynebacterium diphtheriae, synthesize complex cell walls that are rich in very long-chain mycolic acids. These fatty acids are synthesized on the inner leaflet of the cell membrane and are subsequently transported to the periplasmic space as trehalose monomycolates (TMM), where they are conjugated to other cell wall components and to TMM to form trehalose dimycolates (TDM). Mycobacterial TMM, and the equivalent Corynebacterium glutamicum trehalose corynomycolates (TMCM), are transported across the inner membrane by MmpL3, or NCgl0228 and NCgl2769, respectively, although little is known about how this process is regulated. Here, we show that transient acetylation of the mycolyl moiety of TMCM is required for periplasmic export. A bioinformatic search identified a gene in a cell wall biosynthesis locus encoding a putative acetyltransferase (M. tuberculosis Rv0228/C. glutamicum NCgl2759) that was highly conserved in all sequenced Corynebacterineae. Deletion of C. glutamicum NCgl2759 resulted in the accumulation of TMCM, with a concomitant reduction in surface transport of this glycolipid and syntheses of cell wall trehalose dicorynomycolates. Strikingly, loss of NCgl2759 was associated with a defect in the synthesis of a minor, and previously uncharacterized, glycolipid species. This lipid was identified as trehalose monoacetylcorynomycolate (AcTMCM) by mass spectrometry and chemical synthesis of the authentic standard. The in vitro synthesis of AcTMCM was dependent on acetyl-CoA, whereas in vivo [(14)C]-acetate pulse-chase labeling showed that this lipid was rapidly synthesized and turned over in wild-type and genetically complemented bacterial strains. Significantly, the biochemical and TMCM/TDCM transport phenotype observed in the ΔNCgl2759 mutant was phenocopied by inhibition of the activities of the two C. glutamicum MmpL3 homologues. Collectively, these data suggest that NCgl2759 is a novel TMCM mycolyl acetyltransferase (TmaT) that regulates transport of TMCM and is a potential drug target in pathogenic species.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25427102     DOI: 10.1021/cb5007689

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  23 in total

1.  Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.

Authors:  Juan Manuel Belardinelli; Amira Yazidi; Liang Yang; Lucien Fabre; Wei Li; Benoit Jacques; Shiva Kumar Angala; Isabelle Rouiller; Helen I Zgurskaya; Jurgen Sygusch; Mary Jackson
Journal:  ACS Infect Dis       Date:  2016-09-01       Impact factor: 5.084

2.  Disruption of the SucT acyltransferase in Mycobacterium smegmatis abrogates succinylation of cell envelope polysaccharides.

Authors:  Zuzana Palčeková; Shiva K Angala; Juan Manuel Belardinelli; Haig A Eskandarian; Maju Joe; Richard Brunton; Christopher Rithner; Victoria Jones; Jérôme Nigou; Todd L Lowary; Martine Gilleron; Michael McNeil; Mary Jackson
Journal:  J Biol Chem       Date:  2019-05-20       Impact factor: 5.157

3.  Imaging mycobacterial growth and division with a fluorogenic probe.

Authors:  Heather L Hodges; Robert A Brown; John A Crooks; Douglas B Weibel; Laura L Kiessling
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-27       Impact factor: 11.205

4.  Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.

Authors:  John T Williams; Elizabeth R Haiderer; Garry B Coulson; Kayla N Conner; Edmund Ellsworth; Chao Chen; Nadine Alvarez-Cabrera; Wei Li; Mary Jackson; Thomas Dick; Robert B Abramovitch
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

5.  Impact of LytR-CpsA-Psr Proteins on Cell Wall Biosynthesis in Corynebacterium glutamicum.

Authors:  Meike Baumgart; Karin Schubert; Marc Bramkamp; Julia Frunzke
Journal:  J Bacteriol       Date:  2016-10-21       Impact factor: 3.490

6.  Identification of a Membrane Protein Required for Lipomannan Maturation and Lipoarabinomannan Synthesis in Corynebacterineae.

Authors:  Tamaryn J Cashmore; Stephan Klatt; Yoshiki Yamaryo-Botte; Rajini Brammananth; Arek K Rainczuk; Malcolm J McConville; Paul K Crellin; Ross L Coppel
Journal:  J Biol Chem       Date:  2017-02-06       Impact factor: 5.157

7.  Identification of novel lipid modifications and intermembrane dynamics in Corynebacterium glutamicum using high-resolution mass spectrometry.

Authors:  Stephan Klatt; Rajini Brammananth; Sean O'Callaghan; Konstantinos A Kouremenos; Dedreia Tull; Paul K Crellin; Ross L Coppel; Malcolm J McConville
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

8.  MtrP, a putative methyltransferase in Corynebacteria, is required for optimal membrane transport of trehalose mycolates.

Authors:  Arek K Rainczuk; Stephan Klatt; Yoshiki Yamaryo-Botté; Rajini Brammananth; Malcolm J McConville; Ross L Coppel; Paul K Crellin
Journal:  J Biol Chem       Date:  2020-03-26       Impact factor: 5.157

9.  Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria.

Authors:  Jan Madacki; Françoise Laval; Anna Grzegorzewicz; Anne Lemassu; Monika Záhorszká; Michael Arand; Michael McNeil; Mamadou Daffé; Mary Jackson; Marie-Antoinette Lanéelle; Jana Korduláková
Journal:  J Biol Chem       Date:  2018-02-22       Impact factor: 5.157

Review 10.  Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope.

Authors:  Mary Jackson; Casey M Stevens; Lei Zhang; Helen I Zgurskaya; Michael Niederweis
Journal:  Chem Rev       Date:  2020-11-10       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.